GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (NSE:TATVA) » Definitions » Cash Flow from Discontinued Operations

Tatva Chintan Pharma Chem (NSE:TATVA) Cash Flow from Discontinued Operations : ₹0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Tatva Chintan Pharma Chem's cash flow from discontinued operations for the three months ended in Sep. 2024 was ₹0 Mil. It means Tatva Chintan Pharma Chem received ₹0 Mil from the sale of part of business quarterly. Tatva Chintan Pharma Chem's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Tatva Chintan Pharma Chem Cash Flow from Discontinued Operations Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Cash Flow from Discontinued Operations Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial - - - - -

Tatva Chintan Pharma Chem Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tatva Chintan Pharma Chem Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Tatva Chintan Pharma Chem Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (NSE:TATVA) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
NSE:ADVENZYMES BOM:500655 BOM:533333 BOM:506655 BOM:500730 BOM:524051 BOM:538567 BOM:506480 BOM:542665 BOM:524019 LIN XPAR:AI APD SHW ECL XSWX:SIKA SHSE:600309 BOM:500820 DD XSWX:GIVN
Traded in Other Exchanges
543321:India
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Website
https://www.tatvachintan.com
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem Headlines

No Headlines